|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||243.02 - 247.29|
|52 Week Range||198.64 - 258.45|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||25.15|
|Earnings Date||Apr 25, 2022 - Apr 29, 2022|
|Forward Dividend & Yield||7.76 (3.19%)|
|Ex-Dividend Date||May 16, 2022|
|1y Target Est||249.25|
BridgeBio (BBIO) forms an exclusive partnership with Bristol Myers (BMY) to develop and commercialize its SHP2 inhibitor.
Amgen, Altria Group, Uber Technologies, Microchip Technology, and Arista Networks are part of Zacks top Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Altria Group, Inc. (MO), and Uber Technologies, Inc. (UBER).